Abstract
This study aimed to study the serum measurement of clinical value of type II collagen (CTX-II) in syndrome of polycystic ovary in women and indicter as osteoarthritis disease marker analyzed in future levels with a recent available immune enzyme-linked sorbent assay (ELISA) kit. For increasing sensitivity test, the protocol was modified. Levels of CTX-II increased significantly as well total protein, while decrease vitamin D and difference in lipid profile were practical between the patients compared with healthy women’s. The obtained results suggested the monitoring interest of the serum CTX-II for the OA development in patients of polycystic ovary syndrome in women and the relevance of the analysis of multiple time point for this biomarker.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have